News Center
Author: Variantyx
March 15, 2021
Variantyx Secures $20M in Funding for Whole Genome Sequencing Methodology, Advanced Testing Method that Diagnoses Genetic Disorders
- By Variantyx
- Posted in General Company Updates
March 15, 2021 Variantyx, a leader in high complexity hereditary disease testing, today announced that they secured $20M in funding...
February 27, 2021
Whole-genome sequencing and health insurance
By Daryl Spinner, PhD, MBA In the realm of genetic testing, insurance payers have been reluctant to recognize that there...
January 26, 2021
Variantyx Launches Its WGS-Based Prenatal Test for High-Risk Pregnancies, Enters Women’s Health Market
- By Variantyx
- Posted in General Company Updates
January 26, 2021 Variantyx, a leader in high complexity hereditary disease testing, announced today that it will launch its Genomic Unity®...
January 20, 2021
Ethics in Whole Genome Sequencing
By Toni Lewis The use of whole-genome sequencing (WGS) in diagnostic testing brings up the topic of secondary findings or...
January 12, 2021
Variantyx Surpasses 2,500 Genomes Analyzed, Highlights the Value of Its WGS-Based Testing Methodology
January 12, 2021 Clinicians at Variantyx, a leader in high complexity hereditary disease testing, recently completed analysis of their 2,500th...